July 30, 2024 02:41 PM EDT
FDA+

Fil­ing a new drug with clin­i­cal da­ta in 2025? FDA sets fee at $4.3M

Zachary Brennan

Senior Editor

The FDA said Tues­day that com­pa­nies fil­ing new drug and bi­o­log­ics ap­pli­ca­tions next year with clin­i­cal da­ta will each have to pay a fee of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

FDA to re­con­sid­er re­moval of Lil­ly's GLP-1 drug from short­age list, a win for com­pound­ing phar­ma­cies

Pfiz­er gets an FDA win in he­mo­phil­ia af­ter a rough week

Ex­clu­sive: How an ac­ci­den­tal email tipped Pfiz­er off to an ac­tivist in­vestor’s plan

VC firm tar­gets $35M sec­ond fund to back star­tups led by sci­en­tists

Spe­cial re­port 2024: Meet 20 women break­ing new ground in bio­phar­ma R&D

Stealth Bio­Ther­a­peu­tics CEO dis­cuss­es sur­prise ad­comm sup­port for ul­tra-rare dis­ease drug

A service from the Financial Times